- Report
- February 2024
- 106 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 176 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 120 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 150 Pages
Global
From €4084EUR$4,250USD£3,506GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 85 Pages
North America
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 181 Pages
Europe
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 90 Pages
United States
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 160 Pages
Middle East, Africa
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 90 Pages
Europe
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4564EUR$4,750USD£3,918GBP
- Report
- July 2022
- 255 Pages
Global
From €3060EUR$3,185USD£2,627GBP
€4372EUR$4,550USD£3,753GBP
- Report
- October 2022
- 177 Pages
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- October 2022
- 174 Pages
North America
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- October 2022
- 181 Pages
Middle East, Africa
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- October 2022
- 202 Pages
Europe
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- October 2022
- 205 Pages
Asia Pacific
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- February 2024
- 90 Pages
South Korea
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 90 Pages
France
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
United Kingdom
From €4564EUR$4,750USD£3,918GBP
Soliqua is a market of endocrine and metabolic disorder drugs. These drugs are used to treat a variety of conditions, including diabetes, obesity, and thyroid disorders. Soliqua drugs are designed to help patients manage their symptoms and improve their quality of life. They are typically administered orally or through injections.
Soliqua drugs are typically prescribed by endocrinologists and other healthcare professionals. They are often used in combination with lifestyle changes, such as diet and exercise, to help patients achieve better health outcomes.
Some of the companies in the Soliqua market include Novo Nordisk, Sanofi, Eli Lilly, and Merck. These companies are dedicated to developing innovative treatments for endocrine and metabolic disorders. They are committed to providing safe and effective treatments to help patients manage their conditions. Show Less Read more